Literature DB >> 6968912

Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.

K A Krolick, C Villemez, P Isakson, J W Uhr, E S Vitetta.   

Abstract

Highly specific antibodies (affinity-purified or hybridoma) directed against cell surface immunoglobulins on normal or neoplastic murine B lymphocytes were covalently coupled to the A chain of the plant toxin ricin. Such conjugates containing antibodies specific for IgM, for either of the two allotypes of IgD, or for the idiotype of the B cell tumor BCL1 rapidly bound in vitro to cells expressing the corresponding surface antigen and inhibited protein synthesis in such cells. The results demonstrate that A chain-coupled anti-idiotype antibody may be useful as a tumor-specific cytotoxic agent.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6968912      PMCID: PMC350070          DOI: 10.1073/pnas.77.9.5419

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Antitumor effects of antibody-diphtheria toxin conjugates. II. Immunotherapy with conjugates directed against tumor antigens induced by simian virus 40.

Authors:  F L Moolten; N J Capparell; S H Zajdel; S R Cooperband
Journal:  J Natl Cancer Inst       Date:  1975-08       Impact factor: 13.506

3.  Artificial hybrid protein containing a toxic protein fragment and a cell membrane receptor-binding moiety in a disulfide conjugate. II. Biochemical and biologic properties of diphtheria toxin fragment A-S-S-human placental lactogen.

Authors:  T M Chang; A Dazord; D M Neville
Journal:  J Biol Chem       Date:  1977-02-25       Impact factor: 5.157

Review 4.  Affinity chromatography.

Authors:  P Cuatrecasas
Journal:  Annu Rev Biochem       Date:  1971       Impact factor: 23.643

5.  Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis.

Authors:  S Olsnes; A Pihl
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

6.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

7.  Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes.

Authors:  S M Fu; R J Winchester; H G Kunkel
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

8.  Reconstitution of hybrid toxin from Fragment A of diphtheria toxin and a subunit of Wistaria floribunda lectin.

Authors:  T Uchida; M Yamaizumi; E Mekada; Y Okada; M Tsuda; T Kurokawa; Y Sugino
Journal:  J Biol Chem       Date:  1978-09-25       Impact factor: 5.157

Review 9.  Diphtheria.

Authors:  A M Pappenheimer; D M Gill
Journal:  Science       Date:  1973-10-26       Impact factor: 47.728

Review 10.  Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects.

Authors:  T Ghose; A H Blair
Journal:  J Natl Cancer Inst       Date:  1978-09       Impact factor: 13.506

View more
  40 in total

1.  Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.

Authors:  C P Leamon; P S Low
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 2.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

Review 3.  Immunoconjugates: applications in targeted drug delivery for cancer therapy.

Authors:  B P Ram; P Tyle
Journal:  Pharm Res       Date:  1987-06       Impact factor: 4.200

Review 4.  Human tumor-associated antigens identified by monoclonal antibodies.

Authors:  K E Hellström; I Hellström; J P Brown
Journal:  Springer Semin Immunopathol       Date:  1982

Review 5.  Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

Authors:  Michael S Magee; Adam E Snook; Glen P Marszalowicz; Scott A Waldman
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

6.  Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.

Authors:  C W Vogel; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  Ricin A-chain conjugated with monoclonal anti-L1210 antibody. In vitro and in vivo antitumor activity.

Authors:  K Kishida; Y Masuho; M Saito; T Hara; H Fuji
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells.

Authors:  B B Barnett; D F Smee; S M Malek; R W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 9.  Immunotoxin therapy of malignant melanoma.

Authors:  L E Spitler
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

Review 10.  Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxins.

Authors:  S M Rybak; H R Hoogenboom; D L Newton; J C Raus; R J Youle
Journal:  Cell Biophys       Date:  1992 Aug-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.